Naomi James Chief Executive Officer Good morning, everyone. I’m Naomi James, Chief Executive Officer of Ryman Healthcare. Thank you for joining us for our half year results for the 6 months to 30 September 2025. With me today is Matt Prior, who commenced as Chief Financial Officer on the 31st of July; and Hayden Strickett, our Head of Investor Relations. We’re going to be working to get through the presentation in around 30 minutes to allow time for Q&A before we wrap up at midday. Looking at the agenda, I’ll provide an overview of sales, stock, operations and development before handing to Matt, who will speak to the financials and capital management. And I’ll then provide an update on outlook and strategic priorities before opening up for Q&A. Hayden Strickett Starting on Slide 4. As you’ll see from today’s results, we are well on our way to delivering better returns and are doing the things we said we would do when we raised capital at the start of the year. This is the first positive free cash flow result that Ryman has announced in more than a decade. We have made substantial progress towards achieving our cost reduction.
https://seekingalpha.com/article/4848103-ryman-healthcare-limited-ryhty-q2-2026-earnings-call-transcript?source=feed_all_articles
